T Regulatory Cells and Th1/Th2 Cytokines in Peripheral Blood from Tuberculosis Patients

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2010 Mar 23

PMID 20306324

Citations 35

Authors

X-Y He

L Xiao

H-B Chen

J Hao

J Li

Y-J Wang

K He

Y Gao

B-Y Shi

Affiliations

Soon will be listed here.

Abstract

About 10% of people infected with Mycobacterium tuberculosis develop active tuberculosis (TB), and Th1 effector cells and Th1 cytokines play key roles in controlling M. tuberculosis infection. Here, we hypothesise that this susceptibility to M. tuberculosis infection is linked to increased T regulatory (Treg) cells and Th2 cytokines in TB patients. To test this, we recruited 101 participants (71 TB patients, 12 non-TB pulmonary diseases and 18 healthy subjects) and investigated Treg cells and Th1/Th2 cytokines in peripheral blood. CD4(+)CD25(+) T cells and CD4(+)CD25(+)FoxP3(+) T cells significantly increased and IL-5 dramatically decreased in TB patients relative to healthy subjects. CD8(+)CD28(-) T cells, IFN-gamma, TNF-alpha, IL-10 and IL-4 significantly increased in patients with culture and sputum smear-positive pulmonary TB (PTB(+)) compared with healthy subjects. CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) T cells significantly decreased in PTB(+) after one month of chemotherapy. CD4(+), CD4(+)CD25(+) and CD8(+)CD28(+) T cells significantly increased in extra-pulmonary TB patients after one month of chemotherapy. These findings suggest that M. tuberculosis infection induces circulating CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) T cell expansion, which may be related to the progression of M. tuberculosis infection, and that the balance between effector immune responses and suppression immune responses is essential to control M. tuberculosis infection.

Citing Articles

The sound of silent RNA in tuberculosis and the lncRNA role on infection.

Rocha E, Vinhaes C, Araujo-Pereira M, Mota T, Gupte A, Kumar N iScience. 2024; 27(1):108662.

PMID: 38205253 PMC: 10777062. DOI: 10.1016/j.isci.2023.108662.

Clinical Significance of Negative Costimulatory Molecule PD-1/PD-L1 on Peripheral Blood Regulatory T Cell Levels among Patients with Pulmonary Tuberculosis.

Yang C, Dai F, Pulati R, Jiao Y, Xu Q J Trop Med. 2022; 2022:7526501.

PMID: 36035072 PMC: 9410994. DOI: 10.1155/2022/7526501.

Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease.

Rampal R, Kedia S, Wari M, Madhu D, Singh A, Tiwari V Intest Res. 2020; 19(2):232-238.

PMID: 32375209 PMC: 8100372. DOI: 10.5217/ir.2019.09181.

Immune-epidemiological parameters of the novel coronavirus - a perspective.

Saghazadeh A, Rezaei N Expert Rev Clin Immunol. 2020; 16(5):465-470.

PMID: 32237901 PMC: 7157951. DOI: 10.1080/1744666X.2020.1750954.

Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of .

Pahari S, Negi S, Aqdas M, Arnett E, Schlesinger L, Agrewala J Autophagy. 2019; 16(6):1021-1043.

PMID: 31462144 PMC: 7469444. DOI: 10.1080/15548627.2019.1658436.

References

Filaci G, Fenoglio D, Fravega M, Ansaldo G, Borgonovo G, Traverso P . CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol. 2007; 179(7):4323-34. DOI: 10.4049/jimmunol.179.7.4323. View

Quinn K, McHugh R, Rich F, Goldsack L, de Lisle G, Buddle B . Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol. 2006; 84(5):467-74. DOI: 10.1111/j.1440-1711.2006.01460.x. View

Hanekom W . The immune response to BCG vaccination of newborns. Ann N Y Acad Sci. 2006; 1062:69-78. DOI: 10.1196/annals.1358.010. View

Orme I, Miller E, Roberts A, Furney S, Griffin J, Dobos K . T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol. 1992; 148(1):189-96. View

Chatila T . Role of regulatory T cells in human diseases. J Allergy Clin Immunol. 2005; 116(5):949-59. DOI: 10.1016/j.jaci.2005.08.047. View

Burl S, Hill P, Jeffries D, Holland M, Fox A, Lugos M . FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol. 2007; 149(1):117-22. PMC: 1942016. DOI: 10.1111/j.1365-2249.2007.03399.x. View

Yu T, Yang Y, Dong D . [The role of CD8+CD28- regulatory T lymphocytes in pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi. 2007; 30(2):130-2. View

Orme I, Roberts A, Griffin J, Abrams J . Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol. 1993; 151(1):518-25. View

Chen X, Zhou B, Li M, Deng Q, Wu X, Le X . CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol. 2007; 123(1):50-9. DOI: 10.1016/j.clim.2006.11.009. View

10.

Roncador G, Brown P, Maestre L, Hue S, Martinez-Torrecuadrada J, Ling K . Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol. 2005; 35(6):1681-91. DOI: 10.1002/eji.200526189. View

11.

Suzuki M, Konya C, Goronzy J, Weyand C . Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol. 2008; 69(11):781-9. PMC: 2614126. DOI: 10.1016/j.humimm.2008.08.283. View

12.

Roberts T, Beyers N, Aguirre A, Walzl G . Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta , and interleukin-4 mRNA levels. J Infect Dis. 2007; 195(6):870-8. DOI: 10.1086/511277. View

13.

Guyot-Revol V, Innes J, Hackforth S, Hinks T, Lalvani A . Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med. 2005; 173(7):803-10. DOI: 10.1164/rccm.200508-1294OC. View

14.

Hougardy J, Verscheure V, Locht C, Mascart F . In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect. 2007; 9(11):1325-32. DOI: 10.1016/j.micinf.2007.06.004. View

15.

Roy S, Barnes P, Garg A, Wu S, Cosman D, Vankayalapati R . NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol. 2008; 180(3):1729-36. DOI: 10.4049/jimmunol.180.3.1729. View

16.

Chiacchio T, Casetti R, Butera O, Vanini V, Carrara S, Girardi E . Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin Exp Immunol. 2009; 156(3):463-70. PMC: 2691975. DOI: 10.1111/j.1365-2249.2009.03908.x. View

17.

Fontenot J, Rudensky A . A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005; 6(4):331-7. DOI: 10.1038/ni1179. View

18.

Scott-Browne J, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot J, Rudensky A . Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med. 2007; 204(9):2159-69. PMC: 2118702. DOI: 10.1084/jem.20062105. View

19.

Tulunay A, Yavuz S, Direskeneli H, Eksioglu-Demiralp E . CD8+CD28-, suppressive T cells in systemic lupus erythematosus. Lupus. 2008; 17(7):630-7. DOI: 10.1177/0961203308089400. View

20.

Endsley J, Waters W, Palmer M, Nonnecke B, Thacker T, Jacobs Jr W . The calf model of immunity for development of a vaccine against tuberculosis. Vet Immunol Immunopathol. 2008; 128(1-3):199-204. DOI: 10.1016/j.vetimm.2008.10.312. View